Portfolio (Quarterly)
Guide ↗
BRAIDWELL LP
· CIK 0001920938| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | MRVI | MARAVAI LIFESCIENCES HLDGS I | Healthcare | 8,353,287.0 | $24.0M | 0.71% | NEW | — | $2.87 | +49.5% |
| 42 | — | EXACT SCIENCES CORP | — | 414,600.0 | $22.7M | 0.67% | NEW | — | $54.71 | — |
| 43 | — | AKERO THERAPEUTICS INC | — | 475,400.0 | $22.6M | 0.67% | NEW | — | $47.48 | — |
| 44 | ATEC | ALPHATEC HLDGS INC | Healthcare | 1,514,604.0 | $22.0M | 0.65% | NEW | — | $14.54 | -47.3% |
| 45 | KIDS | ORTHOPEDIATRICS CORP | Healthcare | 1,107,770.0 | $20.5M | 0.61% | NEW | — | $18.53 | -3.4% |
| 46 | VKTX | VIKING THERAPEUTICS INC | Healthcare | 759,455.0 | $20.0M | 0.59% | NEW | — | $26.28 | +20.7% |
| 47 | CSTL | CASTLE BIOSCIENCES INC | Healthcare | 822,735.0 | $18.7M | 0.56% | NEW | — | $22.77 | -17.1% |
| 48 | — | BRIGHT MINDS BIOSCIENCES INC | — | 303,685.0 | $18.4M | 0.55% | NEW | — | $60.66 | — |
| 49 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 588,700.0 | $17.7M | 0.53% | NEW | — | $30.08 | -14.2% |
| 50 | HROW | HARROW INC | Healthcare | 342,391.0 | $16.5M | 0.49% | NEW | — | $48.18 | -35.9% |
| 51 | SRPT | SAREPTA THERAPEUTICS INC | Healthcare | 832,100.0 | $16.0M | 0.48% | NEW | — | $19.27 | -3.1% |
| 52 | KYMR | KYMERA THERAPEUTICS INC | Healthcare | 276,692.0 | $15.7M | 0.47% | NEW | — | $56.60 | +49.3% |
| 53 | — | ENGENE HOLDINGS INC | — | 2,266,319.0 | $15.5M | 0.46% | NEW | — | $6.83 | — |
| 54 | DAWN | DAY ONE BIOPHARMACEUTICALS I | Healthcare | 2,181,598.0 | $15.4M | 0.46% | NEW | — | $7.05 | +205.4% |
| 55 | CLDX | CELLDEX THERAPEUTICS INC NEW | Healthcare | 591,689.0 | $15.3M | 0.45% | NEW | — | $25.87 | +21.1% |
| 56 | XNCR | XENCOR INC | Healthcare | 1,246,280.0 | $14.6M | 0.43% | NEW | — | $11.73 | +1.3% |
| 57 | — | AVIDITY BIOSCIENCES INC | — | 331,907.0 | $14.5M | 0.43% | NEW | — | $43.57 | — |
| 58 | EHC | ENCOMPASS HEALTH CORP | Healthcare | 113,335.0 | $14.4M | 0.43% | NEW | — | $127.02 | -15.5% |
| 59 | VERA | VERA THERAPEUTICS INC | Healthcare | 472,739.0 | $13.7M | 0.41% | NEW | — | $29.06 | +36.1% |
| 60 | NEO | NEOGENOMICS INC | Healthcare | 1,771,146.0 | $13.7M | 0.41% | NEW | — | $7.72 | +8.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%